Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)609-611
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume35
Issue number5
DOIs
StatePublished - Oct 12 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this